Research workbench
AlphaFold monomer V2.0 prediction for paxillin (Q8VI36)
Analyse AlphaFold monomer V2.0 prediction for paxillin (Q8VI36) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- Accession
- Q8VI36
- Type
- protein
- Length
- 591 residues
- Chains
- 1
- Collection
- MolNFT v1 / AlphaFold
- Contract
- 0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
- Owner
- 0x6DAA77C4263E74E745cA9c4D8E291e57e8991Cf5
- Molecule
- Paxillin
- UniProt
- Q8VI36
- Pockets
- 3 · best druggability 0.49
Structure
1 distinct chain · 19% helix, 13% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Paxillin | protein | 591 | 19% helix, 13% strand | Q8VI36 |
Pockets
3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 235 | 0.49 | 0.74 | 36 | empty |
| 2 | 73 | 0.33 | 0.75 | 13 | empty |
| 3 | 79 | 0.31 | 0.74 | 16 | empty |
Compared structures
- 6JMU · Crystal structure of GIT1/Paxillin complex · an experimental structure of the same protein · chain A against C, TM-score 0.03
- 6JMU · Crystal structure of GIT1/PAXILLIN complex · an experimental structure of the same protein · chain A against C, TM-score 0.03
- 5W93 · p130Cas complex with paxillin LD1 · an experimental structure of the same protein · chain A against E, TM-score 0.02
- 5W93 · P130CAS complex with paxillin LD1 · an experimental structure of the same protein · chain A against E, TM-score 0.02
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8VI36
- Elsewhere: UniProt Q8VI36 · AlphaFold DB Q8VI36
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.